Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Allos Therapeutics' cancer drug gets FDA's orphan designation, providing market exclusivity
Allos Therapeutics' cancer drug gets FDA's orphan designation, providing market exclusivity
Allos Therapeutics' cancer drug gets FDA's orphan designation, providing market exclusivity
Submitted by
admin
on November 25, 2008 - 9:11am
Source:
Yahoo/AP
Headline:
Allos Therapeutics' cancer drug gets FDA's orphan designation, providing market exclusivity
Do Not Allow Advertisers to Use My Personal information
